KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) EBITDA Margin (2019 - 2026)

GoodRx Holdings' EBITDA Margin history spans 7 years, with the latest figure at 11.65% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 249.0% to 11.65% in Q4 2025 year-over-year; TTM through Dec 2025 was 10.98%, a 267.0% increase, with the full-year FY2025 number at 11.51%, up 263.0% from a year prior.
  • EBITDA Margin hit 11.65% in Q4 2025 for GoodRx Holdings, up from 7.46% in the prior quarter.
  • Over the last five years, EBITDA Margin for GDRX hit a ceiling of 13.2% in Q2 2025 and a floor of 21.3% in Q3 2023.
  • Historically, EBITDA Margin has averaged 3.41% across 5 years, with a median of 5.83% in 2023.
  • The widest YoY moves for EBITDA Margin: up 6246bps in 2021, down -3585bps in 2021.
  • Tracing GDRX's EBITDA Margin over 5 years: stood at 5.51% in 2021, then tumbled by -83bps to 0.94% in 2022, then plummeted by -1086bps to 9.3% in 2023, then skyrocketed by 198bps to 9.15% in 2024, then grew by 27bps to 11.65% in 2025.
  • Business Quant data shows EBITDA Margin for GDRX at 11.65% in Q4 2025, 7.46% in Q3 2025, and 13.2% in Q2 2025.